ArtiFix®
General soft‑tissue sealant (neurosurgery, abdominal, vascular)
Phase 1First‑in‑human trial initiated 2025
Key Facts
Indication
General soft‑tissue sealant (neurosurgery, abdominal, vascular)
Phase
Phase 1
Status
First‑in‑human trial initiated 2025
Company
About Nurami Medical
Nurami leverages electrospun nanofiber technology to deliver next‑generation dura‑repair implants that seal leaks and promote regeneration.
View full company profile